Repligen (RGEN) Non-Current Assets (2011 - 2026)
Repligen's (RGEN) quarterly Non-Current Assets came in at $1.7 billion in Q2 2026, down 5.16% year-over-year from $1.8 billion in Q2 2025, and down 1.12% quarter-over-quarter from $1.8 billion in Q1 2026.
Analysis
Repligen (RGEN) Non-Current Assets (2011 - 2026) Analysis & Trends
Repligen (RGEN) has reported Non-Current Assets for 16 consecutive years, with $1.7 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Assets fell 5.16% year-over-year to $1.7 billion in Q2 2026; TTM through Jun 2026 was $5.1 billion, a 173.94% increase from a year earlier, with the FY2025 full-year figure at $1.8 billion, up 2.76% from the prior year.
- Non-Current Assets was $1.7 billion for Q2 2026 at Repligen, down from $1.8 billion in the prior quarter.
- Over five years, Non-Current Assets peaked at $1.8 billion in Q2 2025 and troughed at $1.4 billion in Q1 2022.
- A 5-year average of $1.7 billion and a median of $1.7 billion in 2023 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets surged 43.76% in 2022 and slipped 5.16% in 2026, its largest moves.
- Over 5 years, Non-Current Assets stood at $1.5 billion in 2022, then advanced by 12.15% to $1.7 billion in 2023, then increased by 2.55% to $1.8 billion in 2024, then grew by 2.76% to $1.8 billion in 2025, then slipped by 3.46% to $1.7 billion in 2026.
- The last three Non-Current Assets figures came in at $1.7 billion (Q2 2026), $1.8 billion (Q1 2026), and $1.8 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 223.99 Bn | 219.93 Bn | 8.34 Bn | 89.81 Bn |
| 2 | Danaher | 141.56 Bn | 137.22 Bn | 3.61 Bn | 78.99 Bn |
| 3 | Agilent Technologies | 40.36 Bn | 38.60 Bn | 1.04 Bn | 9.27 Bn |
| 4 | Illumina | 30.41 Bn | 29.24 Bn | 770.00 Mn | 3.82 Bn |
| 5 | Revvity | 13.50 Bn | 12.48 Bn | 416.87 Mn | 9.75 Bn |
| 6 | Bio-Techne | 11.25 Bn | 10.98 Bn | 211.39 Mn | 1.84 Bn |
| 7 | Bio-Rad Laboratories | 9.88 Bn | 8.26 Bn | 345.80 Mn | 7.23 Bn |
| 8 | Repligen | 9.29 Bn | 8.28 Bn | 110.04 Mn | 1.75 Bn |
| 9 | 10x Genomics | 8.62 Bn | 8.06 Bn | 112.50 Mn | 355.40 Mn |
| 10 | Bruker | 8.16 Bn | 7.94 Bn | 416.00 Mn | 3.83 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.75 Bn |
| Mar 31, 2026 | 1.77 Bn |
| Dec 31, 2025 | 1.81 Bn |
| Sep 30, 2025 | 1.83 Bn |
| Jun 30, 2025 | 1.84 Bn |
| Mar 31, 2025 | 1.82 Bn |
| Dec 31, 2024 | 1.76 Bn |
| Sep 30, 2024 | 1.70 Bn |
| Jun 30, 2024 | 1.71 Bn |
| Mar 31, 2024 | 1.72 Bn |
| Dec 31, 2023 | 1.72 Bn |
| Sep 30, 2023 | 1.54 Bn |
| Jun 30, 2023 | 1.56 Bn |
| Mar 31, 2023 | 1.53 Bn |
| Dec 31, 2022 | 1.53 Bn |
| Sep 30, 2022 | 1.51 Bn |
| Jun 30, 2022 | 1.47 Bn |
| Mar 31, 2022 | 1.44 Bn |
| Dec 31, 2021 | 1.43 Bn |
| Sep 30, 2021 | 1.33 Bn |